Annexon, Inc. is a clinical-stage biopharmaceutical company, which develops a pipeline of novel therapies for patients with classical complement-mediated disorders of the body, eye and brain. It offers drugs that control or target huntington’s and alzheimer’s disease, multiple sclerosis, glaucoma, parkinson’s disease, and spinal muscular atrophy. The company was founded by Ben Barres and Arnon Rosenthal on March 3, 2011 and is headquartered in Brisbane, CA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
96
Frequently Asked Questions
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Annexon Inc market cap is $591.37M.
52 week high is the highest price of a stock in the past 52 weeks, or one year. Annexon Inc 52 week high is $7.18 as of November 22, 2026.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Annexon Inc 52 week low is $3.07 as of November 22, 2026.
Annexon Inc stock price today is $3.10.
Annexon Inc stock price yesterday was $3.41.
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It's calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company's Market Cap by the Net Profit. Annexon Inc's P/E ratio is -3.01.
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. Annexon Inc P/B ratio is 4.1268.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Annexon Inc 50-day moving average is $3.93.